<DOC>
	<DOCNO>NCT03016156</DOCNO>
	<brief_summary>This study seek determine whether smartphone application call CRADLE ( ComputeR Assisted Detection LEukocoria ) potential improve detection leukocoria . There impact participant ' health outcome . This study perform two part , distinct cohort patient . Part 1 assess feasibility various techniques/conditions use CRADLE within patient know leukocoria . Part 2 estimate sensitivity specificity CRADLE detect leukocoria ( use technique select information gather Part 1 ) compare ophthalmoscope , within patient refer clinic suspect leukocoria . PRIMARY OBJECTIVES : - To determine effective usage camera phone application ( CRADLE ) maximize detection leukocoria patient retinoblastoma , congenital cataract , glaucoma . - To estimate sensitivity specificity camera phone application ( CRADLE ) detect leukocoria .</brief_summary>
	<brief_title>Determination Sensitivity Specificity Smartphone Application Detect Retinoblastoma</brief_title>
	<detailed_description>This study utilize three stratum call Stratum I , Stratum II Stratum III . STRATUM I - Infants child know leukocoria diagnose retinoblastoma , cataracts glaucoma eye condition . Participants enrol Stratum I study CRADLE application use doctor appointment . The participant look straight forward doctor stand 1-3 foot away hold device CRADLE application . He slowly move device , , middle , right , leave - lit dim room . The participant videotape photographed appointment . The doctor record result determine CRADLE ( `` normal '' leukocoria versus `` abnormal '' positive leukocoria ) . STRATUM II - Infants child refer eye doctor evaluate leukocoria . Participants enrol Stratum II study ask look straight forward use CRADLE application ( use best method determine Stratum I ) . The doctor also examine participant 's eye ophthalmoscope method . The result CRADLE ophthalmoscope method record compare ( white eye present versus absent , normal versus abnormal described ) . STRATUM III - Infants child receive treatment retinoblastoma . For participant enrol Stratum III , procedures describe Stratum II . After receive informed consent , participant undergo evaluation ophthalmoscope CRADLE Day 1 . Stratum III participant also undergo CRADLE evaluation Days 2 , 3 , 4 .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Hydrophthalmos</mesh_term>
	<criteria>Inclusion Criteria Stratum I : Patient diagnose congenital infantile cataract , congenital glaucoma , retinoblastoma , schedule visit ophthalmologist St. Jude Children 's Research Hospital University Tennessee Hamilton Eye Institute . Patient retinoblastoma newly diagnose , receive &lt; 2 cycle chemoreductive therapy , undergone enucleation . Patient cataract glaucoma receive prior therapy . Inclusion Criteria Stratum II : Patient without prior diagnosis refer ophthalmological evaluation , include leukocoria condition . Inclusion Criteria Stratum III : Patient retinoblastoma undergo ocular salvage treatment . Exclusion Criteria Prior treatment cataract glaucoma Inability unwillingness research participant legal guardian consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>